Direct access :
Origins
A federal hybrid wheat programme was launched in the United States in the 1930s in the wake of research into maize. But the research made no progress to speak of for thirty years.
The discovery of the sterilising values of CHA (Chemical Hybridisation Agents) triggered both public and private research programmes.
Some highlights:
1962 : First cytoplasmic male sterility (CMS) system.
1973 : First Chemical Hybridisation Agent (CHA) developed by Rohm and Haas, an American chemical firm
1974 : First hybrid wheat variety based on a CMS strategy in the United States.
1981 : Hybrid wheat marketed in the United States (Cargill) and Australia (Dekalb).
1982 : Monsanto launches a hybrid wheat programme in the United States and Europe based on the Chemical Hybridisation Agent "GENESIS". Orsan in France announces that they are commencing research into wheat using distinctive CHAs created in its own laboratories.
1985 : Creation and listing of several hybrids following cooperation between HybriTech (Monsanto) and Nordsaat, a German seed company.
First commercial hybrids
1993 : The chemical hybridisation agents CROISOR® (Hybrinova, company founded in 1992) and GENESIS (Monsanto) receive provisional marketing authorisation in France. Their performance at last promises economically-viable seed production.
1994 : French listing of first commercially-developed hybrids: HYNO-PRECIA from Hybrinova and DOMINO from HybriTech. Monsanto also creates varieties in the USA.
1999 : German listing of the first Nordsaat hybrid, HYBNOS 1.
2000s
.jpg)
2003-2004 : Relaunch of sales of hybrid wheats in France, Germany and the United Kingdom and introduction into several European countries: Poland, Czech Republic, Hungary, Portugal, etc.
2003 : CROISOR® receives a French marketing authorisation.
2011 : European marketing autorisation of Sintofen, the active ingredient of CROISOR®, ensures the survival of this hybrid wheat seed production solution.
More informations about the history of CHAs
